1α,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells

Biomedicine and Pharmacotherapy

Volumn 66, Issue 6, 2012, Pages 428-432

  Bessler, Hanna ^a   Djaldetti, Meir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Colon cancer cells; Cytokines; Experimental; Peripheral blood mononuclear cells; Vitamin D

Indexed keywords

CALCITRIOL; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CELL HT 29; CANCER CELL RKO; CANCER PREVENTION; CARCINOGENESIS; CELL INTERACTION; CELL LINE; CELL PROLIFERATION; COLON CANCER; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCOMPETENT CELL; INCUBATION TIME; INFLAMMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; BLOOD BANKS; CALCITRIOL; CARCINOMA; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; CYTOKINES; DOWN-REGULATION; HT29 CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; OSMOLAR CONCENTRATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84866163945     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.06.005     Document Type: Article

References (24)

1. Pohl C., Hombach A., Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 2000, 47:57-70.
2. Xie J., Itzkowitz S.H. Cancer in inflammatory bowel disease. World J Gastroenterol 2008, 14:378-389.
3. Trianrafillidis J.K., Nassioulas G., Kosmidis P.A. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2008, 29:2727-2737.
4. Risques R.A., Lai L.A., Himmetogiu C., Ebaee A., Li L., Feng Z., et al. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res 2011, 71:1669-1679.
5. O'Connor P.M., Lapointe T.K., Beck P.L., Buret A.G. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflamm Bowel Dis 2008, 16:1411-1420.
6. Bessler H., Djaldetti M. Role of the equilibrium between colon cancer and mononuclear cells in cytokine production. Biomed Pharmacother 2010, 64:707-711.
7. Bergman M., Djaldetti M., Salman H., Bessler H. Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells?. Inflammation 2011, 34:22-28.
8. Bergman M., Salman H., Djaldetti M., Bessler H. Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC. Vasc Pharmacol 2011, 54:88-92.
9. Grant W.B., Boucher J. Requirements for vitamin D across the life span. Biol Res Nurs 2011, 13:120-123.
10. Gardini S., Boniol M., Haukka J., Byrnes G., Cox B., Sneyd M.J., et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal carcinoma. Int J Cancer 2011, 128:1414-1424.
11. Touvier M., Chan D.S., Lau R., Aune D., Vieira R., Greenwood D.C., et al. Meta-analysis of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphism and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011, 20:1003-1016.
12. Lee J.E., Li H., Chan A.T., Hollis B.W., Lee I.M., Stampfer M.J., et al. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a mata-analysis of prospective studies. Cancer Prev Res (Phila) 2011, 4:735-743.
13. Toner C.D., Davis C.D., Milner J.A. The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc 2010, 110:1492-1500.
14. Raman M., Milestone A.N., Walters J.R.F., Hart A.L., Ghosh S. Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Therap Adv Gastroenterol 2011, 14:49-62.
15. Castellani M.L., Shaik-Dasthagirisaheb Y.B., Tripodi D., Anogeianaki A., Felaco P., Toniato E., et al. Interrelationship between vitamins and cytokines in immunity. J Biol Regul Homeost Agents 2010, 24:385-390.
16. Kwon H.J., Won Y.S., Suh H.W., Jeon J.H., Shao Y., Yoon S.R., et al. Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-kB activation in hepatocarcinogenesis. J Immunol 2010, 185:3980-3989.
17. Krishnan A.V., Feidman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011, 51:311-336.
18. Bartley J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther 2010, 8:1359-1369.
19. Leow L., Simpson T., Kursons R., Karalus N., Hancox R.J. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology 2011, 16:611-616.
20. Herr C., Greulich T., Koczulla R.A., Meyer S., Zakharkina T., Branscheidt M., et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection and cancer. Respir Res 2011, 18:12-31.
21. Ginanjar E., Sumariyono, Setiati S., Setiyohadi B. Vitamin D and autoimmune disease. Acta Ned Indones 2007, 39:134-141.
22. Kaler P., Augenlicht L., Klampfer L. Macrophage-delivered IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 2009, 28:3892-3902.
23. Ng K., Sargent D.J., Goldberg R.M., Meyerhardt J.A., Green M., Pitot H.C., et al. Vitamin D status in patients with stage IV colorectal cancer: findings from intergroup trial N9741. J Clin Oncol 2011, 29:1599-1606.
24. Oren Y., Shapira Y., Agmon-Levin N., Kivity S., Zafrir Y., Altman A., et al. Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. Isr Med Assoc J 2010, 12:751-756.